The role of type I collagen fragment C1M in knee osteoarthritis. A longitudinal biomarker study using data from the OA-FNIH consortium
Osteoarthritis and Cartilage · 2026-06 · 34 (6) · 899-905
DOI: 10.1016/j.joca.2026.02.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Osteoarthritis and Cartilage, 2026-06. Verfasst von Letizia Satriano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark. Electronic address: lesa@nordicbio.com. Hauptthemen laut MEDLINE: Osteoarthritis, Knee, Collagen Type I, Collagen Type II, Peptide Fragments. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Foundation for the National Institutes of Health.
Abstract (Originalsprache)
OBJECTIVE: To evaluate the association of neoepitopes from type I and II collagen with knee osteoarthritis (OA) progression phenotypes using data from the OA-FNIH biomarker consortium, with comparison to associations of the other biomarkers assessed in this sample during the consortium's phase 1 analysis. DESIGN: Serum (s) and urinary (u) neoepitopes of type I collagen (sC1M) and type II collagen (sC2M and uCTX-II) were analyzed at baseline, and as time-integrated concentrations over 12 (12 M) and 24 months (24 M) in 600 individuals with knee OA divided into non-progressors (n=200), and three groups of progressors based on joint space loss only (JSL) (n=103), pain only (n=103), and JSL and pain (n=194). Logistic regression models were used to evaluate the relationship between the biomarkers and odds of case status. RESULTS: At all-time points lower levels of sC1M, and higher levels of uCTX-II were associated with JSL progression (sC1M 0 M, OR: 0.43 [0.28, 0.68], 12 M OR: 0.43 [0.27, 0.68], 24 M OR:0.55 [0.35, 0.86]; uCTX-II 0 M, OR: 1.54 [1.01, 2.37], 12 M OR: 1.73 [1.11, 2.7], 24 M OR: 2.05 [1.27,3.29]) CONCLUSIONS: The inverse association of C1M with OA progression compared with the positive association of uCTXII indicates that a reduced concentration of one neoepitope (of type I collagen) and an elevated concentration of another (from type II collagen) are each associated with the risk of OA progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark. Electronic address: lesa@nordicbio.com.
- Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark. Electronic address: pef@nordicbio.com.
- Nordic Bioscience, Biomarkers & Research A/S, Herlev, Denmark. Electronic address: mk@NordicBio.com.
- Duke Molecular Physiology Institute and Division of Rheumatology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA. Electronic address: kraus004@duke.edu.
- Department of Rheumatology, Royal North Shore Hospital and Sydney Musculoskeletal Health, Kolling Institute, University of Sydney, Reserve Rd, St., Leonards 2065 NSW, Australia. Electronic address: david.hunter@sydney.e…
- Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: jcollins13@bwh.harvard.edu.
Förderung
- Foundation for the National Institutes of Health
Zitieren
APA
Satriano, L., Frederiksen, P., Karsdal, M. A., Kraus, V. B., Hunter, D. J., Collins, J. E., & Bay-Jensen, A. C. (2026). The role of type I collagen fragment C1M in knee osteoarthritis. A longitudinal biomarker study using data from the OA-FNIH consortium. Osteoarthritis and Cartilage, 34(6), 899-905. https://doi.org/10.1016/j.joca.2026.02.007
Vancouver
Satriano L, Frederiksen P, Karsdal MA, Kraus VB, Hunter DJ, Collins JE, et al. The role of type I collagen fragment C1M in knee osteoarthritis. A longitudinal biomarker study using data from the OA-FNIH consortium. Osteoarthritis and Cartilage. 2026;34(6):899-905. doi:10.1016/j.joca.2026.02.007
BibTeX
@article{Satriano2026,
author = {Satriano, Letizia and Frederiksen, Peder and Karsdal, Morten A and Kraus, Virginia Byers and Hunter, David J and Collins, Jamie E and Bay-Jensen, Anne C},
title = {The role of type I collagen fragment C1M in knee osteoarthritis. A longitudinal biomarker study using data from the OA-FNIH consortium},
journal = {Osteoarthritis and Cartilage},
year = {2026},
volume = {34},
number = {6},
pages = {899--905},
doi = {10.1016/j.joca.2026.02.007}
}
EUVIMED